Nonclassical monocytes: Are they the next therapeutic targets in multiple sclerosis

Bahareh Ajami; Lawrence Steinman

doi:10.1111/imcb.12004

Nonclassical monocytes: Are they the next therapeutic targets in multiple sclerosis

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	125-127
Number of pages	3
Journal	Immunology and Cell Biology
Volume	96
Issue number	2
DOIs	https://doi.org/10.1111/imcb.12004
State	Published - Feb 2018
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Cell Biology

Access to Document

10.1111/imcb.12004

Cite this

@article{b9dcbffa44c84e23bbf5e090b9ca79f6,

title = "Nonclassical monocytes: Are they the next therapeutic targets in multiple sclerosis",

author = "Bahareh Ajami and Lawrence Steinman",

year = "2018",

month = feb,

doi = "10.1111/imcb.12004",

language = "English (US)",

volume = "96",

pages = "125--127",

journal = "Immunology and Cell Biology",

issn = "0818-9641",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Nonclassical monocytes

T2 - Are they the next therapeutic targets in multiple sclerosis

AU - Ajami, Bahareh

AU - Steinman, Lawrence

PY - 2018/2

Y1 - 2018/2

UR - http://www.scopus.com/inward/record.url?scp=85040721460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040721460&partnerID=8YFLogxK

U2 - 10.1111/imcb.12004

DO - 10.1111/imcb.12004

M3 - Comment/debate

C2 - 29352485

AN - SCOPUS:85040721460

SN - 0818-9641

VL - 96

SP - 125

EP - 127

JO - Immunology and Cell Biology

JF - Immunology and Cell Biology

IS - 2

ER -

Nonclassical monocytes: Are they the next therapeutic targets in multiple sclerosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this